Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2018-05-31 | 2018-10-05 | 50956 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-09-12 | 2024-10-11 | 237363 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2023-09-28 | 2023-10-15 | 205495 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-06-23 | 2023-08-04 | 196315 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-10-27 | 2023-12-01 | 208388 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-10-11 | 2018-10-16 | 63793 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-11-10 | 2023-12-01 | 209954 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-02-23 | 2024-03-29 | 220456 |
| APO-MONTELUKAST | 4MG | TABLET (CHEWABLE) | Resolved | 2019-11-20 | 2020-04-07 | 99311 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-01-15 | 2020-04-07 | 72357 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2024-10-31 | 2024-11-15 | 241694 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-08-09 | 2018-10-16 | 57792 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2017-12-14 | 2018-02-15 | 32813 |
| APO-MONTELUKAST | 10MG | TABLET | Resolved | 2023-03-16 | 2023-03-30 | 187241 |
| APO-MOXIFLOXACIN | 0.5% | SOLUTION | Resolved | 2018-01-18 | 2018-03-13 | 36435 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-11-07 | 2018-03-27 | 28556 |
| APO-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-03-10 | 2017-04-27 | 399 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2022-06-06 | 2022-09-06 | 162094 |
| APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Actual shortage | 2025-03-20 | 2025-04-17 | 253064 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DIPYRIDAMOLE-FC TAB 25MG | 25MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101888 |
| APO-DIPYRIDAMOLE-FC TAB 50MG | 50MG | TABLET | Discontinued | 2019-12-20 | 2020-07-30 | 101891 |
| APO-DIPYRIDAMOLE-FC TAB 75MG | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60443 |
| APO-DONEPEZIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60447 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60450 |
| APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
| APO-DOXY CAP 100MG | 100MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-29 | 60459 |
| APO-DOXY TABS 100MG | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4707 |
| APO-ENALAPRIL TAB 10MG | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-12-05 | 60462 |
| APO-ENALAPRIL TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-19 | 60465 |
| APO-ENALAPRIL TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60468 |
| APO-ESCITALOPRAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-11-16 | 60474 |
| APO-ESCITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60471 |
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 |